ENDRA Life Sciences (NDRA) Asset Utilization Ratio (2017 - 2018)
ENDRA Life Sciences' (NDRA) quarterly Asset Utilization Ratio came in at 0.0 in Q4 2018, down 97.19% year-over-year from 0.05 in Q4 2017, and down 75.85% quarter-over-quarter from 0.01 in Q3 2018.
Powered by 
Analysis
ENDRA Life Sciences (NDRA) Asset Utilization Ratio (2017 - 2018) Analysis & Trends
ENDRA Life Sciences (NDRA) has reported Asset Utilization Ratio for 2 consecutive years, with 0.0 the latest figure, recorded in Q4 2018.
- On a quarterly basis, Asset Utilization Ratio fell 97.19% year-over-year to 0.0 in Q4 2018; TTM through Dec 2018 was 0.0, a 97.19% decrease from a year earlier, with the FY2018 full-year figure at 0.0, down 99.13% from the prior year.
- Asset Utilization Ratio was 0.0 for Q4 2018 at ENDRA Life Sciences, down from 0.01 in the prior quarter.
- Over five years, Asset Utilization Ratio peaked at 0.14 in Q2 2017 and troughed at 0.0 in Q4 2018.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Asset Util. (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 0.57 |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 0.65 |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | 0.58 |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | 0.26 |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | 0.39 |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | 0.59 |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 0.79 |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | ENDRA Life Sciences | 8.25 Mn | 2.71 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2018 | 0.00 |
| Sep 30, 2018 | 0.01 |
| Jun 30, 2018 | 0.09 |
| Mar 31, 2018 | 0.07 |
| Dec 31, 2017 | 0.05 |
| Sep 30, 2017 | 0.11 |
| Jun 30, 2017 | 0.14 |